. Characterization of Rad55 phosphorylation sites S19 and S20. Plate assays were performed with W303 strains containing the indicated mutations. YPD plates containing 0% MMS, 0.008% MMS, or 0.02% MMS were incubated at 30° C for two days prior to imaging.
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nmd2 rad55 rad55 nmd2 rad55-S2,8,14,378A rad55-S2,8,14,19,20A rad55-S2,8,14,378A nmd2 rad55-S2,8,14,19,20A nmd2 Plate assay testing the MMS sensitivity of wild type and rad55- S2,8,14,19,20A mutant strains when either wild type Rad55 or 8, 14, 19, 20A is overexpressed. Strains were transformed with a previously described galactose-inducible dual promoter expression plasmid
(1) This plasmid contains both RAD55 (or rad55-S2,8,14,19,20A) and RAD57 under the gal1-10 bidirectional promoter. Cells grown in the presences of galactose express both Rad55 and Rad57 to maintain equal 1:1 stoichiometry. Cells were grown on SD-URA to maintain the plasmid. Overnight cultures were grown in CSM-URA with either 2% glucose or galactose overnight, diluted, and spotted onto SD-URA containing the same sugar and the indicated amount of MMS. -100 his3-11,15 leu2-3,112 trp1-1 ura3-1 RAD5 ade2-n-URA3-ade2-a WDHY2569 ura3-∆::loxP rad55-S2,8,14,19,20A WDHY2945 rad55-S2,8,14,378A WDHY2972 ura3-∆::loxP RAD55-Myc9::TRP1(K. lactis) WDHY3449 ura3-∆::loxP rad55-S2,8,14,19,20A-Myc9: S2, 8, 14, 8, 14, 19, Strains are derivatives of W303 with the common genotype ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 RAD5 except where noted. 
